V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20148062 | 20158361 | 1.53 | 101.3 | Palliative (P) | null | 2020-09-15 | Ixazomib + Lenalidomide | N | null | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100374110 |
| 20152132 | 20158363 | 1 | 83.7 | Palliative (P) | 2019-12-24 | 2021-07-16 | ECarboX | N | N | DARATUMUMAB | 100979015 |
| 20175995 | 20158367 | 1.92 | 58 | Palliative (P) | null | 2021-05-30 | Carboplatin + Liposomal Doxorubicin | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100735644 |
| 20176608 | 20158368 | 1.84 | 97.9 | Palliative (P) | 2021-03-24 | 2021-04-07 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | TOPOTECAN | 101408911 |
| 20183463 | 20158370 | 1.79 | null | Palliative (P) | 2016-05-11 | 2016-11-30 | Ixazomib + Lenalidomide | 02 | N | GEMCITABINE + PACLITAXEL | 101746146 |
| 20187912 | 20158371 | 1.58 | 69.3 | Adjuvant (A) | 2019-03-31 | 2020-02-13 | null | 02 | N | PEMIGATINIB | 101522207 |
| 20199357 | 20158372 | 1.69 | 67.4 | Palliative (P) | 2019-09-18 | 2019-09-29 | FOXTROT TRIAL | N | null | CISPLATIN + DOCETAXEL | 100441603 |
| 20200913 | 20158373 | 1.66 | 53 | Palliative (P) | 2021-06-24 | 2021-08-12 | Ripretinib | 02 | N | BEVACIZUMAB + FLUOROURACIL + OXALIPLATIN | 100060037 |
| 20204722 | 20158374 | null | null | Palliative (P) | 2018-02-19 | 2018-07-06 | Cetuximab + FLUOROURACIL | 99 | N | CARFILZOMIB + LENALIDOMIDE | 100936390 |
| 20205619 | 20158375 | 1.65 | 79.5 | null | 2018-08-29 | 2018-10-16 | Capecitabine+Trastuzumab 21day Load | 01 | null | HYDROXYCARBAMIDE | 101747743 |
| 20210958 | 20158376 | 1.64 | null | Palliative (P) | 2018-10-31 | 2018-11-24 | Carboplatin + Pemetrexed | N | N | GO2 TRIAL | 100639536 |
| 20211066 | 20158377 | 1.82 | 56.7 | null | 2021-03-17 | 2022-03-22 | CAPE + OXALIPLATIN + TRASTUZUMAB | 01 | N | DARATUMUMAB | 100559799 |
| 20212094 | 20158378 | 1.69 | 113.95 | Adjuvant (A) | 2016-07-24 | 2017-06-01 | Trabectedin | 02 | Y | PHITT B OR C CISPLATIN | 100203168 |
| 20215936 | 20158379 | 1.51 | 103.8 | null | 2019-12-05 | 2019-12-17 | Bevacizumab + CAPECITABINE + OXALIPLATIN | 02 | N | GO2 TRIAL | 101630201 |
| 20219760 | 20158380 | 1.77 | 19.2 | Curative (C) | 2018-04-28 | 2018-04-28 | Bortezomib + Cyclophos + Dex | N | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100369989 |
| 20225316 | 20158382 | 1.61 | 56 | Disease modification (D) | 2018-06-15 | 2018-07-13 | Docetaxel + Gemcitabine (prior RT) | 02 | N | RITUXIMAB | 101453265 |
| 20024555 | 20158384 | 1.8 | 7.1 | Palliative (P) | 2016-09-11 | 2016-09-21 | CAV | N | null | CARBOPLATIN + VINORELBINE | 101122635 |
| 20046077 | 20158385 | 1.71 | 74.8 | null | 2019-07-12 | 2020-01-11 | Bevacizumab + Irinotecan + MdG | 02 | null | BALLAD TRIAL | 100829353 |
| 20046135 | 20158386 | 1.75 | 63 | 03 | 2020-06-17 | 2020-06-29 | Trabectedin | 02 | Y | CARBOPLATIN + RALTITREXED | 100166988 |
| 20048490 | 20158387 | 1.71 | 66 | Palliative (P) | 2017-09-13 | 2017-09-16 | ECF | 02 | null | PHITT D CARBOPLATIN/DOXORUBICIN | 100913682 |
| 20056056 | 20158388 | 1.92 | 76 | null | 2020-01-29 | 2020-05-13 | CISPLATIN + TEYSUNO | 01 | null | PERTUZUMAB + TRASTUZUMAB | 101725014 |
| 20070602 | 20158390 | 1.6 | 77.7 | Curative (C) | 2018-06-12 | 2018-06-12 | Cabazitaxel | 02 | N | ABEMACICLIB + FULVESTRANT | 101417571 |
| 20073243 | 20158391 | 1.65 | 79.75 | Palliative (P) | 2020-07-25 | 2020-08-09 | Carboplatin + Docetaxel | 02 | Y | RITUXIMAB | 100198859 |
| 20205657 | 20158392 | 1.65 | 71.15 | Curative (C) | 2020-01-28 | 2020-04-24 | SCOPE 2 TRIAL | N | N | ESPAC TRIAL | 101761467 |
| 20048721 | 20158394 | 1.77 | 85 | Palliative (P) | 2021-09-15 | 2021-09-15 | Carboplatin + Cetuximab (>Cycle 2) | N | N | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | 101266698 |
| 20128239 | 20162134 | 1.78 | 99.7 | Palliative (P) | 2020-06-08 | 2020-06-13 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101686525 |
| 20128240 | 20162135 | 1.72 | 88.7 | Adjuvant (A) | 2018-05-19 | 2018-05-26 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100345505 |
| 20128241 | 20162136 | 1.78 | 62 | Palliative (P) | 2017-04-24 | 2018-02-08 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100020109 |
| 20128311 | 20162138 | 1.82 | 76 | Palliative (P) | 2020-11-30 | 2020-12-28 | Capecitabine + Oxaliplatin 14day | 02 | N | CAPECITABINE + OXALIPLATIN | 100675913 |
| 20128382 | 20162139 | 1.68 | 89 | Adjuvant (A) | 2019-06-04 | 2019-06-25 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100564034 |
| 20128401 | 20162140 | 1.75 | 81 | Curative (C) | 2017-07-28 | 2017-08-11 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101141246 |
| 20128408 | 20162141 | 1.67 | 57.6 | Palliative (P) | 2019-02-20 | 2019-04-29 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101070110 |
| 20128438 | 20162142 | null | null | null | 2020-07-20 | 2020-08-03 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100357023 |
| 20128445 | 20162143 | 1.77 | 84.3 | Palliative (P) | 2018-06-21 | 2018-07-13 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101468201 |
| 20128461 | 20162144 | 1.72 | 74.8 | Neo-adjuvant (N) | 2017-12-24 | 2018-01-15 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101833728 |
| 20128468 | 20162145 | 1.75 | 62.8 | Adjuvant (A) | 2017-02-15 | 2017-06-08 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101372788 |
| 20128490 | 20162147 | 1.75 | 72 | null | 2018-12-18 | 2018-12-30 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101361716 |
| 20128496 | 20162148 | 1.8 | 48.8 | Curative (C) | 2022-04-08 | 2022-04-30 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100217227 |
| 20128517 | 20162149 | 0.8 | 98 | 03 | null | 2021-11-15 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101012600 |
| 20128538 | 20162150 | 1.77 | 71.6 | Palliative (P) | 2020-06-21 | 2020-06-24 | Capecitabine + Oxaliplatin 14day | N | N | CAPECITABINE + OXALIPLATIN | 101084788 |
| 20128541 | 20162151 | 1.75 | 94.2 | null | 2017-04-21 | 2017-05-05 | Capecitabine + Oxaliplatin 14day | N | null | CAPECITABINE + OXALIPLATIN | 100501043 |
| 20128560 | 20162152 | 1.71 | 62.5 | Adjuvant (A) | null | 2019-07-02 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101754217 |
| 20128585 | 20162153 | 1.83 | 57 | Curative (C) | 2021-12-14 | 2022-01-03 | Capecitabine + Oxaliplatin 14day | 02 | N | CAPECITABINE + OXALIPLATIN | 100894286 |
| 20128630 | 20162154 | 1.77 | 80.3 | null | 2017-11-20 | 2017-12-14 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100074458 |
| 20128698 | 20162155 | 1.62 | 60.3 | Adjuvant (A) | 2018-01-24 | 2018-02-10 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100813334 |
| 20128708 | 20162156 | 1.77 | 85 | Palliative (P) | null | 2021-01-17 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101020828 |
| 20128729 | 20162157 | 1.5 | 97.5 | null | 2020-02-08 | 2020-11-29 | Capecitabine + Oxaliplatin 14day | N | N | CAPECITABINE + OXALIPLATIN | 100533195 |
| 20128733 | 20162158 | 1.91 | 110 | Adjuvant (A) | 2018-10-19 | 2018-11-02 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101220370 |
| 20128756 | 20162159 | 1.87 | 52.65 | Curative (C) | 2016-12-09 | 2016-12-12 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101113041 |
| 20128793 | 20162160 | 1.95 | 79.4 | Palliative (P) | 2020-04-16 | 2020-04-17 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100052032 |